pregnancy - MGH Center for Women's Mental Health

Cognitive Behavioral Therapy Used to Treat Depression in Pregnancy

Mood disorders and symptoms during pregnancy and the postpartum period are not uncommon and affect women across the world. In spite of relatively high rates of depression among childbearing women, there are often inadequate resources for treatment, particularly in poorer countries. In countries lacking resources, health care is often managed by community health workers or individuals with basic health care training who provide care to difficult-to-reach populations. There are often few mental health professionals, leaving many women without adequate treatment. In an attempt to provide treatment to a greater number of women, some investigators are attempting to train community health workers to provide some psychotherapy as part of their standard duties.

By MGH Center for Women's Mental Health|2016-03-14T12:20:53-04:00January 13th, 2009|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|0 Comments

Dr. Lee Cohen talks with Dr. Oz about Pregnancy and Mood Disorders on Oprah.com

Earlier this year, Dr. Lee S. Cohen, Director of the MGH Center for Women's Mental Health, spoke with Dr. Mehmet Oz from Oprah.com and a woman with bipolar disorder about mood disorders during pregnancy and weighing the risks of treatment options.

By MGH Center for Women's Mental Health|2015-08-12T12:15:34-04:00December 8th, 2008|Psychiatric Disorders During Pregnancy|1 Comment

Exercise and Depression

Exercise plays a vital role in achieving and maintaining good health. Along with numerous other health benefits, recent studies have shown that exercise alleviates symptoms of depression and may be useful in treating mild to moderate major depressive disorder (MDD). A study by Dunn and colleagues (2005) examined the efficacy of exercise as a treatment for depression, along with the dose-response relationship of exercise and reduction in depressive symptoms.

By MGH Center for Women's Mental Health|2015-08-12T12:05:36-04:00November 24th, 2008|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|2 Comments

Substance Abuse Treatment During Pregnancy Improves Outcomes

Despite efforts over the last decade to increase awareness regarding the negative effects of alcohol and other drug use during pregnancy, substance abuse among pregnant women continues to be a significant problem in the United States. The 2003 National Household Survey on Drug Use and Health indicated that 9.3% of pregnant women used alcohol and 4.3% percent of pregnant women used illicit drugs. In other countries, the prevalence of substance use and abuse may be even higher. For example, in a recent survey of pregnant women in Ireland, 54% admitted to drinking alcohol during pregnancy.

By MGH Center for Women's Mental Health|2015-08-12T12:03:46-04:00November 17th, 2008|Psychiatric Disorders During Pregnancy|2 Comments

Folic Acid Supplementation is Recommended for All Women Taking Anticonvulsants and Planning Pregnancy

Given recent discussions within our group and with our colleague, Lewis Holmes, MD, chief of the Genetics and Teratology Unit at Massachusetts General Hospital for Children and director of the North American AED (Antiepileptic Drug) Pregnancy Registry, I wanted to expand upon a previous blog post. In the initial post, I wrote that women who take certain medications, like mood stabilizers or antiepileptic drugs, are advised to take increased doses of folic acid before pregnancy and throughout pregnancy.

By MGH Center for Women's Mental Health|2015-08-12T11:51:27-04:00November 11th, 2008|Psychiatric Disorders During Pregnancy|3 Comments

Depression during Pregnancy Increases the Risk of Preterm Delivery

A new study reported in Human Reproduction supports what many other studies have found, that untreated depression during pregnancy increases the likelihood of delivering before 37 weeks gestation.

By MGH Center for Women's Mental Health|2015-08-12T11:47:05-04:00November 3rd, 2008|Psychiatric Disorders During Pregnancy|0 Comments

Identifying Postpartum Depression: A Three Question Screening Tool

While postpartum depression is common among new mothers, our ability to reliably detect this illness remains poor. Recent studies have indicated that most obstetricians report that they screen for postpartum psychiatric problems at routine follow-up visits but typically do not use standardized instruments to assess for postpartum depression. Unfortunately, studies which have measured the success of routine screening suggest that without the use of standardized screening tools like the Edinburgh Postnatal Depression Scale, many women with postpartum depression are not identified.

By MGH Center for Women's Mental Health|2015-08-12T11:45:03-04:00October 27th, 2008|Postpartum Psychiatric Disorders|11 Comments

National Depression Screening Day – October 10, 2008

This Friday, October 10, is Screening for Mental Health's National Depression Screening Day, an effort to raise awareness for depression and its treatment.

By MGH Center for Women's Mental Health|2018-07-11T13:33:56-04:00October 9th, 2008|Women's Mental Health|0 Comments

Post-Traumatic Stress Disorder (PTSD) Following Childbirth

Post-Traumatic Stress Disorder (PTSD) after childbirth is an understudied condition. Traditionally, much of the data have been based on case reports, indicating that PTSD can occur following a range of childbirth and child loss situations, including long or complicated labor, severe pain with labor or delivery, cesarean section, and unanticipated pregnancy outcome, such as child loss, miscarriage or infant birth defects. PTSD related to childbirth is frequently overlooked by physicians; the relative newness of the diagnosis and lack of literature on this topic are factors which may hinder recognition of this disorder.

By MGH Center for Women's Mental Health|2015-08-11T15:21:40-04:00October 8th, 2008|Postpartum Psychiatric Disorders|4 Comments

PPHN and SSRIs: Another Study Evaluating the Risk

In 2006, Chambers and colleagues published an article linking SSRI use during late pregnancy to an increased risk of persistent pulmonary hypertension in the newborn (PPHN). Based on the results of this analysis, the authors estimated the risk of PPHN to be about 1% in infants exposed to SSRIs late in pregnancy (after 20 weeks). However, subsequent studies did not demonstrate a significant association between PPHN and SSRI usage. A new study, this one relying upon data from the Swedish Medical Birth Register, has observed an elevated risk of PPHN among SSRI-exposed infants.

By MGH Center for Women's Mental Health|2015-08-11T14:44:41-04:00September 16th, 2008|Psychiatric Disorders During Pregnancy|0 Comments